Studying bone marrow failure over time
Part of Blood & lymphatic, Genetic & congenital clinical trials.
This study looks at the natural course of bone marrow failure conditions, both inherited and acquired. It aims to understand how these diseases progress over time, which may help guide future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 2 years or older.
- You must have a bone marrow failure condition (either inherited or acquired), or have a first-degree family member with such a condition.
- You must be willing to travel to the NIH Clinical Center in Bethesda, Maryland for consultations and testing.
- You must be able to give informed consent, or have a legal guardian who can.
- For certain groups, you must have a known genetic mutation in telomere-related genes, or show very short telomeres with at least two related symptoms like low blood counts, liver scarring, or lung fibrosis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study tests a special “T-cell depleted” transplant plan for people with inherited bone marrow failure disorders (Fanconi anemia or T-Beta-thalassemia—or “TBD”). It may help restore healthy blood production while lowering the chance of certain transplant complications.
This study analyzes blood, bone marrow, and medical information from people with bone marrow failure syndromes (BMFS) and healthy volunteers to better understand these conditions and find new ways to help patients.
This Phase 2 trial tests a stem cell (bone marrow) transplant approach to restore bone marrow function and immune function in people with certain inherited immune problems. If you have one of these conditions and a suitable donor, the study may offer a path to rebuild blood and immune systems.
This study carefully evaluates people with myelodysplastic syndromes (MDS) and closely related blood disorders using detailed medical, blood, and bone marrow testing. The goal is to better understand these conditions and how they progress, which may help guide future care.
This study looks at why people with inherited bone marrow failure syndromes (rare genetic conditions affecting blood cell production) have higher cancer risk. Researchers want to understand the genetic and medical factors that increase cancer likelihood, which could help doctors monitor and protect affected patients and their families.
This trial studies how different blood cancers and early (pre-cancer) blood conditions work, using tumor/blood tissue samples. It may help researchers learn more about disease biology for future treatments, with little to no extra risk if samples come from routine care.
Hear when a new Severe Aplastic Anemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.